6-((4-(Aminomethyl)benzyl)oxy)-7H-purin-2-amine, 95.0%, 250mg

(1-Benzyl-4-hydroxypiperidin-3-yl)methyl acetate, 98%, 500mg

1,2,3,5-Tetrahydro-8-thia-5,7-diaza-cyclopenta[a]indene-4-one, 95.0%, 1g

Benzyl (2R,4R)-4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate hydrochloride, 95%, 1g

DIETHYL CYCLOPROPANE-1,2-DICARBOXYLATE, 95.0%, 250mg

1-AMINO-7-BOC-7-AZASPIRO[3.5]NONANE HCL, 95.0%, 250mg

4-ETHYNYL-N,N-DIPHENYLANILINE, 95.0%, 250mg

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-asparagine>98.0%(HPLC)(T)1g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiazolo[5,4-b]pyridine, 97%, 1g

3-(4-methylphenyl)-4H-1,2,4-triazole, 98%, 1g

Recipiente di reazione a flangia piatta cilindrico, graduato (2) Fondo piatto, DN 200, 215 mm, Altezza, 430 mm, 1 Pezzo

4-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 250mg

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(furan-2-yl)propanoic acid, 95.0%, 250mg